Physician Wealth Advisors’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.14K Buy
237
+86
+57% +$1.09K ﹤0.01% 1345
2026
Q2
$1.67K Buy
+151
New +$924 ﹤0.01% 1579
2026
Q1
– Sell
-111
Closed -$1.08K – 2204
2025
Q4
$1.08K Hold
111
– – ﹤0.01% 1579
2025
Q3
$466 Hold
111
– – ﹤0.01% 1839
2025
Q2
$1.03K Buy
111
+38
+52% +$332 ﹤0.01% 1408
2025
Q1
$712 Buy
+73
New +$903 ﹤0.01% 1270

Other funds holding REPL

Physician Wealth Advisors's REPL Position: Q3 2026 in Review

Physician Wealth Advisors increased its Replimune Group (REPL) stake by 57% in Q3 2026, buying an estimated $1.09K and bringing the position to 237 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Physician Wealth Advisors first reported a position in REPL in Q1 2025 and has held it in 6 quarters since. 91 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Physician Wealth Advisors held 237 shares of Replimune Group worth $3.14K as of Q3 2026.
  • Physician Wealth Advisors bought 86 Replimune Group shares in Q3 2026, an estimated $1.09K.
  • Replimune Group made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1345 holding.
  • Physician Wealth Advisors first reported a position in Replimune Group in Q1 2025 and has held it in 6 quarters since.
  • 91 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.